CAG slams the govt for procurement of branded drugs
An amount of Rs 11.81 crore could have been saved if generic drugs had been procured, said a CAG report which was tabled in Parliament on Friday.
New Delhi: The Comptroller and Auditor General of India (CAG) has criticized the Central Government Health Scheme (CGHS) for buying high-priced branded drugs instead of the generic variety.An amount of Rs 11.81 crore could have been saved if generic drugs had been procured, said a report which was tabled in Parliament on Friday.[caption id="attachment_1091321" align="alignleft" width="380"]
This image of branded medicines have been used for representational purposes only. AFP. [/caption]The CAG in its report also points to the delay in procurement of drugs ranging from two to six months after asking a consulting firm for procuring drugs required by CGHS centres.The CAG audit has also revealed losses to the tune of Rs 5.06 crore in tuberculosis division of the health ministry."Branded drugs continue to be preferred over generic drugs despite adverse remarks of the parliamentary committee. This caused significant financial burden on the exchequer," said the report. IANS
India rejects Pakistan's 'baseless' claims at Asean, says Indus Waters Treaty to remain on hold
India successfully tests long-range 'Kusha' air defence missile system
Indian trucker arrested in US over alleged theft of $3 million worth of tungsten powder
China has dominated Myanmar’s rare earth mines — now India eyes deal to harness country’s critical minerals
CJP protest in Delhi: New videos of stone pelting, violence emerge as police, agitators trade charges